ClinicalTrials.gov
public full text
Public Domain
Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE
This is an investigator-initiated trial aimed at assessing the safety and efficacy of ultra-fast autologous BCMA/CD70-targeted CAR-T cells in the treatment of refractory systemic lupus erythematosus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IMPROVING CAR-T CELL PERFORMANCE WITH TARGETED DELIVERY OF CYTOKINES AND CYTOKINE SIGNALS#929225
- Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases#1010625
- Promoting Immune Health by Intermittent Fasting: a Pilot Study#890601
- To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT#435750
- RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL#825785
Record · ID 886275
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive